(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide

C166H176N24O6 — CID 167609264

IUPAC(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide
SMILESCc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@@H](C)N[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@@H](C)N[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@H](C)N[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@H](C)N[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1
InChIInChI=1S/4C28H30N4O.2C27H28N4O/c4*1-20-9-11-22(12-10-20)17-21(2)30-27(24-7-5-4-6-8-24)28(33)31-26-15-13-23(14-16-26)25-18-29-32(3)19-25;2*1-20-8-10-21(11-9-20)16-17-28-26(23-6-4-3-5-7-23)27(32)30-25-14-12-22(13-15-25)24-18-29-31(2)19-24/h4*4-16,18-19,21,27,30H,17H2,1-3H3,(H,31,33);2*3-15,18-19,26,28H,16-17H2,1-2H3,(H,30,32)/t2*21-,27+;2*21-,27-;2*26-/m101010/s1
InChIKeyKURNXPHXIXITSY-MRPWSIOTSA-N
MW2603.40 g/mol
LogP31.00
Rot. Bonds48

About (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide

(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide (PubChem CID 167609264) has the molecular formula C166H176N24O6 and a molecular weight of 2603.40 g/mol. Its IUPAC name is (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide.

Molecular Properties

Compound Name(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide
PubChem CID167609264
Molecular FormulaC166H176N24O6
Molecular Weight2603.40 g/mol
Exact Mass2601.42
IUPAC Name(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide
SMILESCc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@@H](C)N[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@@H](C)N[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@H](C)N[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@H](C)N[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1
InChIInChI=1S/4C28H30N4O.2C27H28N4O/c4*1-20-9-11-22(12-10-20)17-21(2)30-27(24-7-5-4-6-8-24)28(33)31-26-15-13-23(14-16-26)25-18-29-32(3)19-25;2*1-20-8-10-21(11-9-20)16-17-28-26(23-6-4-3-5-7-23)27(32)30-25-14-12-22(13-15-25)24-18-29-31(2)19-24/h4*4-16,18-19,21,27,30H,17H2,1-3H3,(H,31,33);2*3-15,18-19,26,28H,16-17H2,1-2H3,(H,30,32)/t2*21-,27+;2*21-,27-;2*26-/m101010/s1
InChIKeyKURNXPHXIXITSY-MRPWSIOTSA-N
XLogP31.00
TPSA353.70 Ų
H-Bond Donors12
H-Bond Acceptors24
Rotatable Bonds48
Heavy Atoms196
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002603.40
LogP ≤ 531.00
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1024

Analyze (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide?
The IUPAC name of (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide (CID 167609264) is (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide.
What is the SMILES notation for (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide?
The canonical SMILES for (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide is Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@@H](C)N[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@@H](C)N[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@H](C)N[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.Cc1ccc(C[C@H](C)N[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cc2)c2ccccc2)cc1.
What is the InChIKey of (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide?
The InChIKey is KURNXPHXIXITSY-MRPWSIOTSA-N. The full InChI is InChI=1S/4C28H30N4O.2C27H28N4O/c4*1-20-9-11-22(12-10-20)17-21(2)30-27(24-7-5-4-6-8-24)28(33)31-26-15-13-23(14-16-26)25-18-29-32(3)19-25;2*1-20-8-10-21(11-9-20)16-17-28-26(23-6-4-3-5-7-23)27(32)30-25-14-12-22(13-15-25)24-18-29-31(2)19-24/h4*4-16,18-19,21,27,30H,17H2,1-3H3,(H,31,33);2*3-15,18-19,26,28H,16-17H2,1-2H3,(H,30,32)/t2*21-,27+;2*21-,27-;2*26-/m101010/s1.
What are the key properties of (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide?
(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide has a molecular weight of 2603.40 g/mol, XLogP of 31.00, 48 rotatable bonds, 12 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2R)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2S)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide;(2R)-2-[[(2S)-1-(4-methylphenyl)propan-2-yl]amino]-N-[4-(1-methylpyrazol-4-yl)phenyl]-2-phenylacetamide is sourced from PubChem (CID 167609264), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).